Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

What the S&P 500 might be telling us

Keep an eye on the top gainers and losers in Thursday's session.

S&P 500's all-time high, investigators visit the Fed, Allbirds' rebrand and more in Morning Squawk

Jury finds that Ticketmaster and Live Nation had an anticompetitive monopoly over big concert venues

The S&P 500 Slid by Nearly 9% at One Point During the Iran Conflict. Here Is the Historical Case for Why Staying Invested Through Volatility Like This Has Always Paid Off.